• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

经导管主动脉瓣置换术后无导线起搏器患者的起搏诱导性心肌病

Pacing-Induced Cardiomyopathy in a Patient With a Leadless Pacemaker Following Transcatheter Aortic Valve Replacement.

作者信息

Ko Euihong, Isotani Akihiro, Shirai Shinichi, Ando Kenji

机构信息

Kokura Memorial Hospital Kitakyushu Japan.

出版信息

Clin Case Rep. 2024 Dec 5;12(12):e9674. doi: 10.1002/ccr3.9674. eCollection 2024 Dec.

DOI:10.1002/ccr3.9674
PMID:39649509
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11620844/
Abstract

Conduction disturbances following transcatheter aortic valve replacement (TAVR) sometimes require permanent pacemaker implantation. However, little is known about the pacing-induced cardiomyopathy (PICM) in leadless pacemaker (LP) after TAVR. Here we present a case of heart failure due to PICM 6 months after TAVR which was successfully treated with LOT-CRT upgrade.

摘要

经导管主动脉瓣置换术（TAVR）后发生的传导障碍有时需要植入永久性起搏器。然而，对于TAVR后无导线起搏器（LP）所致的起搏诱导性心肌病（PICM）却知之甚少。在此，我们报告1例TAVR术后6个月因PICM导致心力衰竭的病例，该病例通过升级为左束支区域起搏心脏再同步治疗（LOT-CRT）获得成功治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/11620844/e1ff63ba5569/CCR3-12-e9674-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/11620844/91ec9a5888d3/CCR3-12-e9674-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/11620844/21816888f0ad/CCR3-12-e9674-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/11620844/12de70d2bc20/CCR3-12-e9674-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/11620844/de73d234e734/CCR3-12-e9674-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/11620844/e1ff63ba5569/CCR3-12-e9674-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/11620844/91ec9a5888d3/CCR3-12-e9674-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/11620844/21816888f0ad/CCR3-12-e9674-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/11620844/12de70d2bc20/CCR3-12-e9674-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/11620844/de73d234e734/CCR3-12-e9674-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/11620844/e1ff63ba5569/CCR3-12-e9674-g002.jpg

相似文献

1
Pacing-Induced Cardiomyopathy in a Patient With a Leadless Pacemaker Following Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后无导线起搏器患者的起搏诱导性心肌病
Clin Case Rep. 2024 Dec 5;12(12):e9674. doi: 10.1002/ccr3.9674. eCollection 2024 Dec.
2
Outcomes in patients with electrocardiographic left ventricular dyssynchrony following transcatheter aortic valve replacement.经导管主动脉瓣置换术后心电图左心室不同步患者的结局
Heart Rhythm. 2023 Jan;20(1):22-28. doi: 10.1016/j.hrthm.2022.08.001. Epub 2022 Aug 7.
3
MICRA AV implantation after transcatheter aortic valve replacement.经导管主动脉瓣置换术后的 MICRA AV 植入。
Cardiovasc Revasc Med. 2024 Jun;63:31-35. doi: 10.1016/j.carrev.2024.01.005. Epub 2024 Jan 12.
4
Incidence of pacing-induced cardiomyopathy: left bundle branch area pacing versus leadless pacing.起搏诱导性心肌病的发生率：左束支区域起搏与无导线起搏
J Interv Card Electrophysiol. 2025 Apr 21. doi: 10.1007/s10840-025-02048-1.
5
Predictors of right ventricular pacing and pacemaker dependence in transcatheter aortic valve replacement patients.经导管主动脉瓣置换术患者右心室起搏及起搏器依赖的预测因素
J Interv Card Electrophysiol. 2018 Jan;51(1):77-86. doi: 10.1007/s10840-017-0303-1. Epub 2017 Dec 19.
6
Comparison of Patient Outcomes Between Leadless vs Transvenous Pacemakers Following Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后无导线起搏器与经静脉起搏器患者结局的比较。
JACC Cardiovasc Interv. 2024 Aug 12;17(15):1779-1791. doi: 10.1016/j.jcin.2024.05.030. Epub 2024 Jul 17.
7
Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Device: The United Kingdom Experience.经导管主动脉瓣置换术使用可重定位 LOTUS 装置后的传导异常和永久性起搏器植入：英国经验。
JACC Cardiovasc Interv. 2017 Jun 26;10(12):1247-1253. doi: 10.1016/j.jcin.2017.03.044.
8
Implantation of Leadless Pacemaker for the Development of New Left Bundle Branch Block and Symptomatic Pause Following Transcatheter Aortic Valve Replacement.无导线起搏器植入用于经导管主动脉瓣置换术后新发左束支传导阻滞及症状性停搏的治疗
Heart Views. 2019 Oct-Dec;20(4):170-171. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_91_18. Epub 2019 Nov 14.
9
Transcatheter aortic valve replacement without previous conduction disturbances: The importance of preventing iatrogenic pacemaker implantation.无既往传导障碍的经导管主动脉瓣置换术：预防医源性起搏器植入的重要性。
Catheter Cardiovasc Interv. 2020 Apr 1;95(5):991-992. doi: 10.1002/ccd.28880.
10
Incidence of pacing-induced cardiomyopathy in pacemaker-dependent patients is lower with leadless pacemakers compared to transvenous pacemakers.与经静脉起搏器相比，无导线起搏器用于依赖起搏器的患者时，起搏诱导性心肌病的发生率较低。
J Cardiovasc Electrophysiol. 2021 Feb;32(2):477-483. doi: 10.1111/jce.14814. Epub 2020 Nov 25.

本文引用的文献

1
Left bundle branch pacing set to outshine biventricular pacing for cardiac resynchronization therapy?左束支起搏在心脏再同步治疗中会比双心室起搏更具优势吗？
World J Cardiol. 2024 Apr 26;16(4):186-190. doi: 10.4330/wjc.v16.i4.186.
2
Risk of permanent pacemaker implantation following transcatheter aortic valve replacement: Which factors are most relevant?经导管主动脉瓣置换术后永久性起搏器植入的风险：哪些因素最为相关？
World J Cardiol. 2024 Feb 26;16(2):49-53. doi: 10.4330/wjc.v16.i2.49.
3
Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry.
5 年随访的无导线起搏器：Micra 经导管起搏系统上市后注册研究。
Eur Heart J. 2024 Apr 7;45(14):1241-1251. doi: 10.1093/eurheartj/ehae101.
4
Novel predictors of permanent pacemaker implantation following transcatheter aortic valve replacement.经导管主动脉瓣置换术后永久性起搏器植入的新型预测指标。
World J Cardiol. 2023 Nov 26;15(11):582-598. doi: 10.4330/wjc.v15.i11.582.
5
Effectiveness of conduction system pacing for cardiac resynchronization therapy: A systematic review and network meta-analysis.心脏再同步治疗中传导系统起搏的有效性：系统评价和网络荟萃分析。
J Cardiovasc Electrophysiol. 2023 Nov;34(11):2342-2359. doi: 10.1111/jce.16086. Epub 2023 Sep 28.
6
Electrical Resynchronization and Clinical Outcomes During Long-Term Follow-Up in Intraventricular Conduction Delay Patients Applied Left Bundle Branch Pacing-Optimized Cardiac Resynchronization Therapy.左束支区域起搏优化心脏再同步治疗在伴有室内传导延迟患者中的长期随访中对电同步和临床结果的影响。
Circ Arrhythm Electrophysiol. 2023 Sep;16(9):e011761. doi: 10.1161/CIRCEP.122.011761. Epub 2023 Aug 14.
7
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.2023 年 HRS/APHRS/LAHRS 心脏生理起搏指南：预防和减轻心力衰竭。
Heart Rhythm. 2023 Sep;20(9):e17-e91. doi: 10.1016/j.hrthm.2023.03.1538. Epub 2023 May 20.
8
Anatomical location of leadless pacemaker and the risk of pacing-induced cardiomyopathy.无导线起搏器的解剖位置与起搏诱导性心肌病的风险。
J Cardiovasc Electrophysiol. 2023 Jun;34(6):1418-1426. doi: 10.1111/jce.15925. Epub 2023 May 10.
9
Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy.随机试验：左束支起搏与双心室起搏治疗心脏再同步治疗。
J Am Coll Cardiol. 2022 Sep 27;80(13):1205-1216. doi: 10.1016/j.jacc.2022.07.019.
10
Cardiac resynchronization therapy via left bundle branch pacing vs. optimized biventricular pacing with adaptive algorithm in heart failure with left bundle branch block: a prospective, multi-centre, observational study.左束支区域起搏与优化的双心室起搏伴自适应算法治疗左束支传导阻滞心力衰竭：一项前瞻性、多中心、观察性研究。
Europace. 2022 May 3;24(5):807-816. doi: 10.1093/europace/euab249.